Barclays PLC Sells 93,416 Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS)

Barclays PLC lowered its stake in Axcelis Technologies, Inc. (NASDAQ:ACLS) by 57.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 68,111 shares of the semiconductor company’s stock after selling 93,416 shares during the quarter. Barclays PLC’s holdings in Axcelis Technologies were worth $7,143,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Signaturefd LLC grew its stake in Axcelis Technologies by 348.9% in the second quarter. Signaturefd LLC now owns 211 shares of the semiconductor company’s stock valued at $30,000 after purchasing an additional 164 shares in the last quarter. Blue Trust Inc. grew its stake in shares of Axcelis Technologies by 223.8% in the second quarter. Blue Trust Inc. now owns 272 shares of the semiconductor company’s stock valued at $39,000 after buying an additional 188 shares in the last quarter. Ashton Thomas Private Wealth LLC acquired a new position in Axcelis Technologies during the second quarter worth $39,000. Isthmus Partners LLC increased its holdings in Axcelis Technologies by 87.3% during the second quarter. Isthmus Partners LLC now owns 33,270 shares of the semiconductor company’s stock worth $47,000 after buying an additional 15,507 shares during the last quarter. Finally, Meeder Asset Management Inc. bought a new stake in Axcelis Technologies during the second quarter worth $69,000. Institutional investors own 89.98% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on ACLS. Needham & Company LLC reissued a “hold” rating on shares of Axcelis Technologies in a research report on Friday, November 8th. Benchmark cut Axcelis Technologies from a “buy” rating to a “hold” rating in a report on Friday, November 8th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $167.33.

Axcelis Technologies Stock Performance

NASDAQ ACLS opened at $70.97 on Thursday. The stock has a market cap of $2.31 billion, a PE ratio of 10.50, a P/E/G ratio of 2.36 and a beta of 1.53. The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.29 and a current ratio of 4.45. The firm has a 50-day moving average of $82.48 and a 200-day moving average of $106.47. Axcelis Technologies, Inc. has a 52-week low of $69.35 and a 52-week high of $158.61.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.